Application and prospects of high-throughput screening for in vitro neurogenesis
- PMID: 35949394
- PMCID: PMC9244953
- DOI: 10.4252/wjsc.v14.i6.393
Application and prospects of high-throughput screening for in vitro neurogenesis
Abstract
Over the past few decades, high-throughput screening (HTS) has made great contributions to new drug discovery. HTS technology is equipped with higher throughput, minimized platforms, more automated and computerized operating systems, more efficient and sensitive detection devices, and rapid data processing systems. At the same time, in vitro neurogenesis is gradually becoming important in establishing models to investigate the mechanisms of neural disease or deve lopmental processes. However, challenges remain in generating more mature and functional neurons with specific subtypes and in establishing robust and standardized three-dimensional (3D) in vitro models with neural cells cultured in 3D matrices or organoids representing specific brain regions. Here, we review the applications of HTS technologies on in vitro neurogenesis, especially aiming at identifying the essential genes, chemical small molecules and adaptive microenvironments that hold great prospects for generating functional neurons or more reproductive and homogeneous 3D organoids. We also discuss the developmental tendency of HTS technology, e.g., so-called next-generation screening, which utilizes 3D organoid-based screening combined with microfluidic devices to narrow the gap between in vitro models and in vivo situations both physiologically and pathologically.
Keywords: Cell differentiation; Cellular microenvironments; High-throughput screening; Neurogenesis; Stem cells; Three-dimensional cell culture.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures



Similar articles
-
A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.Elife. 2020 Nov 3;9:e52904. doi: 10.7554/eLife.52904. Elife. 2020. PMID: 33138918 Free PMC article.
-
Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.J Mol Cell Biol. 2020 Aug 1;12(8):630-643. doi: 10.1093/jmcb/mjaa036. J Mol Cell Biol. 2020. PMID: 32678871 Free PMC article.
-
Microscale screening systems for 3D cellular microenvironments: platforms, advances, and challenges.Cell Mol Life Sci. 2015 Jan;72(2):237-49. doi: 10.1007/s00018-014-1738-5. Epub 2014 Oct 2. Cell Mol Life Sci. 2015. PMID: 25274061 Free PMC article. Review.
-
Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.Mov Disord. 2021 Dec;36(12):2745-2762. doi: 10.1002/mds.28775. Epub 2021 Sep 8. Mov Disord. 2021. PMID: 34498298
-
Microfluidic three-dimensional cell culture of stem cells for high-throughput analysis.World J Stem Cells. 2019 Oct 26;11(10):803-816. doi: 10.4252/wjsc.v11.i10.803. World J Stem Cells. 2019. PMID: 31693013 Free PMC article. Review.
Cited by
-
Current progress and challenges in the development of brain tissue models: How to grow up the changeable brain in vitro?J Tissue Eng. 2024 Mar 20;15:20417314241235527. doi: 10.1177/20417314241235527. eCollection 2024 Jan-Dec. J Tissue Eng. 2024. PMID: 38516227 Free PMC article. Review.
-
Virtual screening: hope, hype, and the fine line in between.Expert Opin Drug Discov. 2025 Feb;20(2):145-162. doi: 10.1080/17460441.2025.2458666. Epub 2025 Jan 27. Expert Opin Drug Discov. 2025. PMID: 39862145 Review.
-
High-throughput sequencing: a breakthrough in molecular diagnosis for precision medicine.Funct Integr Genomics. 2025 Jan 22;25(1):22. doi: 10.1007/s10142-025-01529-w. Funct Integr Genomics. 2025. PMID: 39838192 Review.
References
-
- Penchovsky R, Stoilova CC. Riboswitch-based antibacterial drug discovery using high-throughput screening methods. Expert Opin Drug Discov. 2013;8:65–82. - PubMed
-
- Schuster A, Erasimus H, Fritah S, Nazarov PV, van Dyck E, Niclou SP, Golebiewska A. RNAi/CRISPR Screens: from a Pool to a Valid Hit. Trends Biotechnol. 2019;37:38–55. - PubMed
-
- Liu B, Li S, Hu J. Technological advances in high-throughput screening. Am J Pharmacogenomics. 2004;4:263–276. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous